Acisclo M. Marxuach-Cuétara

Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis

M. Rodríguez‐Torres, Carlos F. Ríos‐Bedoya, Grisell Ortiz‐Lasanta et al. · Annals of Hepatology · 2008 · 41 citations · Full text

Medicine, Endocrinology, Immunology +17

Progression to Cirrhosis in Latinos With Chronic Hepatitis C: Differences in Puerto Ricans With and Without Human Immunodeficiency Virus Coinfection and Along Gender

M. Rodríguez‐Torres, Carlos F. Ríos‐Bedoya, José F. Rodríguez‐Orengo et al. · Journal of Clinical Gastroenterology · 2006 · 34 citations

Medicine, Infectious Diseases, Internal Medicine +17

Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: A paired liver biopsy study

M. Rodríguez‐Torres, José F. Rodríguez‐Orengo, Carlos F. Ríos‐Bedoya et al. · Journal of Hepatology · 2007 · 29 citations

Medicine, Infectious Diseases, Pathology +17

Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy

M. Rodríguez‐Torres, José F. Rodríguez‐Orengo, Carlos F. Ríos‐Bedoya et al. · Journal of Clinical Virology · 2006 · 23 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa‐2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks

M. Rodríguez‐Torres, Carlos F. Ríos‐Bedoya, Grisell Ortiz‐Lasanta et al. · Journal of Medical Virology · 2008 · 10 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16